US Stock MarketDetailed Quotes
GTHP GUIDED THERAPEUTICS INC
- 0.109000
- +0.021700+24.86%
15min DelayTrading Apr 29 12:00 ET
6.06MMarket Cap-1557P/E (TTM)
0.109000High0.090000Low19.06KVolume0.090000Open0.087300Pre Close1.87KTurnover0.09%Turnover RatioLossP/E (Static)55.61MShares0.30000052wk High-0.89P/B2.31MFloat Cap0.06200052wk Low--Dividend TTM21.21MShs Float0.800000Historical High--Div YieldTTM21.76%Amplitude0.062000Historical Low0.097000Avg Price1Lot Size
GUIDED THERAPEUTICS INC Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -18.05%-1.75M | 0.88%-336K | 22.71%-473K | -25.50%-438K | -178.77%-499K | 7.10%-1.48M | -313.21%-339K | 17.19%-612K | 49.57%-349K | 44.06%-179K |
| Net income from continuing operations | 19.63%-3.49M | 78.64%-386K | 38.57%-677K | -68.32%-1.56M | -71.40%-869K | -109.61%-4.34M | -306.07%-1.81M | -1,720.59%-1.1M | 21.41%-925K | 1.93%-507K |
| Operating gains losses | -145.48%-201K | -115.88%-127K | 93.82%-17K | 41.57%-52K | -183.33%-5K | 224.51%442K | 887.65%800K | 62.74%-275K | -133.71%-89K | -84.21%6K |
| Depreciation and amortization | 18.06%85K | 4.76%22K | 16.67%21K | 29.41%22K | 25.00%20K | -13.25%72K | 31.25%21K | -73.13%18K | --17K | --16K |
| Other non cash items | -50.48%156K | -18.75%39K | 28.13%41K | -356.00%-384K | 441.18%460K | -29.21%315K | -2.04%48K | -78.95%32K | -42.08%150K | 666.67%85K |
| Change In working capital | -119.16%-105K | 53.15%170K | 84.35%-18K | -112.00%-45K | -219.77%-212K | 602.56%548K | -72.79%111K | 66.57%-115K | 482.65%375K | 58.04%177K |
| -Change in receivables | -118.75%-3K | --0 | --0 | -120.00%-2K | -116.67%-1K | 172.73%16K | --0 | --0 | 600.00%10K | --6K |
| -Change in inventory | -44.83%-84K | 145.45%15K | -174.07%-74K | 1,000.00%11K | -3,700.00%-36K | -275.76%-58K | -273.68%-33K | -167.50%-27K | 104.00%1K | 200.00%1K |
| -Change in payables and accrued expense | -64.75%43K | 34.11%173K | 153.09%43K | -110.00%-21K | -280.95%-152K | -10.29%122K | -77.41%129K | 82.00%-81K | 80.00%-10K | 29.23%84K |
| -Change in other current assets | -71.63%103K | -6.45%29K | 86.67%28K | -92.37%30K | 121.05%16K | 217.48%363K | 115.20%31K | 113.39%15K | 1,971.43%393K | -371.43%-76K |
| -Change in other current liabilities | -17.91%-79K | -31.25%-21K | -5.26%-20K | -17.65%-20K | -20.00%-18K | -19.64%-67K | -6.67%-16K | 53.66%-19K | ---17K | ---15K |
| -Change in other working capital | -149.42%-85K | ---26K | 266.67%5K | -2,050.00%-43K | -111.86%-21K | -41.89%172K | --0 | -101.38%-3K | ---2K | 785.00%177K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -18.05%-1.75M | 0.88%-336K | 22.71%-473K | -25.50%-438K | -178.77%-499K | 7.10%-1.48M | -313.21%-339K | 17.19%-612K | 49.57%-349K | 44.06%-179K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 0 | -121.43%-31K | 25.00%-3K | 160.00%3K | -325.00%-17K | -1,300.00%-14K |
| Net PPE purchase and sale | --0 | --0 | --0 | --0 | --0 | -121.43%-31K | 25.00%-3K | 160.00%3K | -325.00%-17K | -1,300.00%-14K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | --0 | --0 | -121.43%-31K | 25.00%-3K | 160.00%3K | -325.00%-17K | -1,300.00%-14K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.25%24K | 566.67%196K | -105.38%-154K | -147.13%-41K | -91.64%23K | 53.85%3.18M | 20.75%-42K | 687.88%2.86M | -76.55%87K | -80.16%275K |
| Net issuance payments of debt | 23.70%-412K | 40.00%-45K | 53.61%-154K | 4.65%-41K | -91.11%-172K | -145.45%-540K | -41.51%-75K | -311.46%-332K | -118.45%-43K | 83.84%-90K |
| Net common stock issuance | --0 | --0 | ---- | ---- | ---- | --1.39M | ---4K | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | -81.27%436K | 551.35%241K | --0 | --0 | -46.58%195K | --2.33M | --37K | --1.8M | --130K | --365K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.25%24K | 566.67%196K | -105.38%-154K | -147.13%-41K | -91.64%23K | 53.85%3.18M | 20.75%-42K | 687.88%2.86M | -76.55%87K | -80.16%275K |
| Net cash flow | ||||||||||
| Beginning cash position | 259.72%2.31M | -72.90%731K | 204.48%1.36M | 153.38%1.84M | 259.72%2.31M | 253.30%643K | 398.52%2.7M | -51.63%446K | -41.86%725K | 253.30%643K |
| Current changes in cash | -203.05%-1.72M | 63.45%-140K | -127.85%-627K | -71.68%-479K | -680.49%-476K | 262.47%1.67M | -475.49%-383K | 690.81%2.25M | 14.15%-279K | -92.30%82K |
| End cash Position | -74.46%591K | -74.46%591K | -72.90%731K | 204.48%1.36M | 153.38%1.84M | 259.88%2.31M | 259.88%2.31M | 398.52%2.7M | -51.63%446K | -41.86%725K |
| Free cash flow | -15.63%-1.75M | 1.75%-336K | 22.33%-473K | -19.67%-438K | -158.55%-499K | 5.98%-1.51M | -320.65%-342K | 18.15%-609K | 47.41%-366K | 39.88%-193K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg